Abstract
Hypofractionated radiotherapy may offer similar local control and toxicity outcomes in the management of soft tissue sarcomas (STS) compared to standard fractionation. Shorter-course radiotherapy regimens can reduce overall treatment time and delays in surgical intervention or systemic treatment. It may also improve patient compliance and reduce healthcare costs. In this comprehensive review, the current evidence on the use of hypofractionated radiotherapy in the treatment of STS is synthesized, and an overview is provided for how hypofractionated radiotherapy may be used in the treatment of STS.
Publication Date
3-31-2025
Content Type
Article
PubMed ID:
Citation
Zerey, M. M., Gul, A., Kalman, N. S., & Hall, M. D. (2025). Hypofractionated Radiotherapy for Soft Tissue Sarcomas. Cancers, 17(7), 1170. https://doi.org/10.3390/cancers17071170
Comments
This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. © 2025